1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Collaborative Research Development Grants is sponsored by Ovarian Cancer Research Alliance (OCRA). OCRA's Collaborative Research Development Grants support research projects. While primarily focused on ovarian cancer, the broad nature of cancer research may allow for projects with relevance to rare kidney cancers if the scientific rationale is strong and translatable.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers, likely within academic or research institutions. Specific eligibility will be detailed in the Request for Proposals (RFP). Confirm the full requirements on the funder's own website before applying.
The current listing shows up to $900,000 over 3 years (OCRA monetary support), plus Microsoft Azure computing credits and data science support (in-kind). Verify award ceilings, matching requirements, and allowable costs on the funder's own website.
Collaborative Research Development Grants is funded by Ovarian Cancer Research Alliance (OCRA). Verify program details on the funder's own website before applying.
Start from the funder's website linked on this page and look for its grants or funding section — the link goes to the funder's site rather than a specific solicitation.
Past winners and funding trends for this program
Early Career Investigator Grant is sponsored by Ovarian Cancer Research Alliance (OCRA). OCRA offers Early Career Investigator Grants to support promising scientists in ovarian cancer research. While specific details for the 2027 grant are not yet fully released, OCRA's grant programs generally aim to fund research at all career stages to improve detection, diagnosis, and treatment of ovarian cancer.
Collaborative Research Development Grant - Microsoft AI for Health is a grant from the Ovarian Cancer Research Alliance (OCRA) and the Global Ovarian Cancer Research Consortium that funds AI-driven research to personalize ovarian cancer care. The inaugural AI Accelerator Grant awards $1 million in research funding plus an additional $1 million in compute support from Microsoft's AI for Good Lab to international research teams. The program supports projects examining whether artificial intelligence can improve prediction of survival and treatment response in ovarian cancer. Eligible applicants include academic and clinical researchers with the capacity to lead large-scale international collaborative AI studies in oncology. Check OCRA's grant portal for future cycles and letter of intent requirements.
On October 16, 2026, at COP17 in Yerevan, nine private funders including the Bezos Earth Fund, Re:wild, Rainforest Trust, the Critical Ecosystem Partnership Fund and Fondation Franklinia launched the Species Recovery Alliance, coordinating more than $500 million over five years for species listed as Extinct in the Wild, Critically Endangered or Endangered. The money is not pooled, there is no open call, and it is unclear how much of it is new. The Bezos Earth Fund's share is $100 million. Here is how the alliance works, what it is likely to fund, and how field organizations can position themselves.
Read articleOn October 16, 2026, the Spitzer Trust, the Grantham Environmental Trust and Sequoia Climate Foundation announced over $36 million for cooling emissions — part of a $100 million, four-year effort routed through the Super Pollutant Action Alliance and the Clean Cooling Collaborative. It is intermediary money with no open RFP, which changes how you reach it.
Read articleProp. 38, the $8.4 billion immunology research bond, led 56% to 44% the morning after the November 3, 2026 election. Here is what the statute says about who can get the grant money, the 20% indirect cap, and the timeline.
Read article